New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Business News and Headlines
SEC Filings, Earing Reports, Press Releases
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Robert Baker buys 1,036 Shares
Posted by: gurufocus (IP Logged)
Date: September 27, 2012 04:00PM

CEO of Progenics Pharmaceuticals Inc. (PGNX) Mark Robert Baker buys 1,036 shares of PGNX on 09/26/2012 at an average price of $3.32 a share.

Progenics Pharmaceuticals, Inc. has a market cap of $113.2 million; its shares were traded at around $3.01 with and P/S ratio of 1.3.

CEO Recent Trades:


  • CEO Mark Robert Baker bought 815 shares of PGNX stock on 08/22/2012 at the average price of 4.23. Mark Robert Baker owns at least 42,641 shares after this. The price of the stock has decreased by 28.84% since.
  • CEO Mark Robert Baker bought 346 shares of PGNX stock on 07/25/2012 at the average price of 10.04. Mark Robert Baker owns at least 41,826 shares after this. The price of the stock has decreased by 70.02% since.
  • CEO Mark Robert Baker bought 375 shares of PGNX stock on 06/27/2012 at the average price of 9.27. Mark Robert Baker owns at least 41,480 shares after this. The price of the stock has decreased by 67.53% since.
  • CEO Mark Robert Baker bought 445 shares of PGNX stock on 05/23/2012 at the average price of 7.81. Mark Robert Baker owns at least 41,105 shares after this. The price of the stock has decreased by 61.46% since.
  • CEO Mark Robert Baker bought 348 shares of PGNX stock on 04/25/2012 at the average price of 10.07. Mark Robert Baker owns at least 40,660 shares after this. The price of the stock has decreased by 70.11% since.

Directors and Officers Recent Trades:


  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 07/02/2012 at the average price of 9.79. Robert J Israel owns at least 35,050 shares after this. The price of the stock has decreased by 69.25% since.
  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 06/01/2012 at the average price of 8.51. Robert J Israel owns at least 38,383 shares after this. The price of the stock has decreased by 64.63% since.
  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 05/01/2012 at the average price of 10.93. Robert J Israel owns at least 38,383 shares after this. The price of the stock has decreased by 72.46% since.
  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 04/02/2012 at the average price of 9.85. Robert J Israel owns at least 38,383 shares after this. The price of the stock has decreased by 69.44% since.


For the complete insider trading history of PGNX, click here.


Stocks Discussed: PGNX,
Rate this post:




Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial